Sana biotechnology to present at the 40th annual j.p. morgan healthcare conference

Seattle, jan. 04, 2022 (globe newswire) -- sana biotechnology, inc. (nasdaq: sana), a company focused on creating and delivering engineered cells as medicines, today announced that it will webcast its presentation at the 40th annual j.p. morgan healthcare conference at 10:30 a.m. pt on tuesday, january 11, 2022. the presentation will feature a business overview and update by steve harr, sana's president and chief executive officer.
SANA Ratings Summary
SANA Quant Ranking